Summaries & Associations of Study Results
TR-298 Dimethyl morpholinophosphoramidate
Target Organs and Levels of Evidence
NTP Technical Report Number 298
Produced from Chemtrack Database 09/19/01
| CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
|---|---|---|---|---|
| DIMETHYL MORPHOLINOPHOSPHORAMIDATE 597-25-1 |
11/02/84 | STIMULANT FOR NERVE AGENTS IN CHEMICAL DEFENSE TRAINING; NOT PRODUCED COMMERCIALLY IN U.S. | Gavage R: 0,150,300,600, FM: 0,300,600, MM: 0,150,300 MG/KG/50 PER GROUP | Litton Bionetics, Inc. |
| LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
| MR: SOME EVIDENCE | HEMATOPOIETIC SYSTEM: LEUKEMIA 14/50 21/50 19/50 25/50 | |||
| FR: SOME EVIDENCE | HEMATOPOIETIC SYSTEM: LEUKEMIA 9/50 13/50 12/49 18/50 | |||
| MM: NO EVIDENCE | ||||
| FM: NO EVIDENCE | ||||
Web page last updated on February 10, 2006
